Abstract
Glycogen storage disease type II (GSD II), Pompe's disease, is caused by the deficiency of acid α-D-glucosidase (GAA) in lysosome and is the most common form of GSD in Taiwan. Most cases are the infantile form. The disease is relentless and most patients die of cardiac failure and respiratory tract infection in the first year of life. At present, no treatment has been proved effective for this fatal disease. The applicability of enzyme replacement therapy is under investigation. However, high price and transient efficiency are the major problems to be solved. Accordingly, gene therapy by viral method has been conducted. In this study we constructed a plasmid that contained 5′-shortened BglII–NotI fragment human GAA cDNA, downstream of CMV promoter and bovine growth hormone polyadenylation signal, as well as AAV ITR region. When fibroblasts obtained from GSD II patients were cultured and infected with rAAV-GAA, the GAA activity of the fibroblasts increased four- to five-fold. Using acid maltase deficient (AMD) Japanese quail as the animal model, rcAAV-GAA 0.1 ml per site (1 × 109-10 particles), totally 10 different sites to make 1 ml (1 × 1010–11 particles), was injected into unilateral deep pectoral muscle of AMD quails. Medium (hepes) was only injected in the same way into the contralateral deep pectoral muscle to serve as control. Four days after injection, PAS staining showed disappearance of the glycogenosomes with regeneration of myocytes surrounding the intramuscular injected area as compared with the contralateral muscle of the same birds. Using anti-GAA monoclonal antibody, GAA was demonstrated on the regenerated myocytes by immunohistochemical staining and absent on the contralateral muscle of the same birds. Nevertheless, T lymphocytes infiltration was noted in both the rcAAV-GAA and hepes (medium) injected muscles and more prominent in the rcAAV-GAA-injected site. Functional evaluation demonstrated that wing flapping movement improved with wide flapping in the rAAV-GAA injected side, but not in the counterpart. Unfortunately, these histochemical and functional improvements faded away in 14 days, probably due to destruction of rcAAV by cell-mediated immunity of infiltrated T cells. Taken together, the present study suggests that rAAV can enter either human or quail cells and express and effectively reduce the glycogen accumulation in the skeletal muscle of AMD quails. These preliminary results are similar to these of low-dose rGAA replacement therapy. The mechanisms underlying the induction of cell-mediated immunity are unknown. How to elevate the number of packaged AAV, enhance the infectivity of AAV and reduce cell-mediated immunity must be solved in the future.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lin CY, Hwang B, Hsiao KJ, Jin YR . Pompe's disease in Chinese and prenatal diagnosis by determination of α-glucosidase activity J Inher Metab Dis 1987 10: 11–17
Hwang B, Meng CCL, Lin CY, Hsu HC . Clinical analysis of five infants with glycogen storage disease of the heart-Pompe's disease Jpn Heart J 1986 27: 25–34
Shieh JJ, Lin CY . Frequent mutation in chinese patients with infantile type of GSD II in Taiwan: evidence for a founder effect Hum Mutat 1998 11: 306–312
Shieh JJ, Wang CY, Lin CY . Point mutation in Pompe disease in Chinese J Inher Metab Dis 1994 17: 145–148
Lin CY, Shieh JJ . Molecular study on the infantile form of Pompe disease in Chinese in Taiwan Acta Paed Sin 1996 37: 115–121
Carter PJ, Samulski RJ . Adeno-associated viral vectors as gene delivery vehicles (review) Int J Mol Med 2000 6: 17–27
Dutheil N, Shi F, Dupressoir T, Linden RM . Adeno-associated virus site-specifically integrates into a muscle-specific DNA region Proc Natl Acad Sci USA 2000 97: 4862–4866
Collaco RF, Cao X, Trempe JP . A helper virus-free packaging system for recombinant adeno-associated virus vectors Gene 1999 238: 397–405
Xiao X, Li J, Samulski RJ . Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus J Virol 1998 72: 2224–2243
Walvoort HC . Glycogen storage disease in animals and their potential value as models of human disease J Inher Metab Dis 1983 6: 3–16
Usuki F, Ishiura S, Sugita H . Developmental study of α-glucosidase in Japanese quails with acid maltase deficiency Muscle Nerve 1986 9: 537–543
Suhara Y, Ishiura S, Tsukahara T, Sugita H . Mature 98,000-dalton acid α-glucosidase is deficient in Japanese quails with acid maltase deficiency Muscle Nerve 1989 12: 670–678
Miyagawa-Tomita S et al. Pathological study of Japanese quail embryo with acid α-glucosidase deficiency during early development Acta Neuropathol 1996 92: 249–254
DeBarsy T, Van Hoof F . Enzyme replacement therapy with purified human acid I-glucosidase in type II glycogenosis Tager JM, Hooghwinkel GJM, Daems WT (eds); Enzyme Replacement Therapy in Lysosomal Storage Disease North-Holland 1974 pp 277–279
Hug G, Schubert WK . Hepatic lysosomes in Pompe's disease: disappearance during glucosidase administration J Clin Invest 1967 46: 1073–1073
Nacy MD, Lobel P, Breitmeyer J . 46 kD mannose 6-phosphate receptor: cloning, expression and homology to 215 kD mannose 6-phosphate receptor Cell 1987 50: 181–192
Ziegler RJ et al. Correction of enzymatic and lysosomal storage defects in Fabry mice by adenovirus-mediated gene transfer Hum Gene Ther 1999 10: 1667–1682
Kikuchi T et al. Clinical and metabolic correction of Pompe disease by enzyme therapy in acid maltase-deficient quail J Clin Invest 1998 101: 827–833
Yang HW et al. Recombinant human acid α-glucosidase corrects acid α-glucosidase-deficient human fibroblasts, quail fibroblasts, and quail myoblasts Pediatr Res 1998 43: 374–380
Tollefsen SE, Sadow JL, Rotwein P . Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation Proc Natl Acad Sci USA 1989 86: 1543–1547
Bijvoet AGA et al. Pathological features of glycogen storage disease type II highlighted in the knockout mouse model J Pathol 1999 189: 416–424
During M . adeno-associated virus as a gene delivery system Adv Drug Del Rev 1997 27: 83
Van Hove JLK et al. High level production of recombinant human lysosomal acid α-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with pompe disease Proc Natl Acad Sci USA 1996 93: 65–70
Lin CY et al. Preparation of monoclonal antibodies agains acid α-D-glucosidase for study of Chinese glycogenesis type II patients Hybridoma 1992 11: 493–505
Reuser AJJ, Kroos M, OudeElferink RPJ, Tager JM . Defects in synthesis, phosphorylation and maturation of acid alpha-glucosidase in glycogenosis type II J Biol Chem 1985 260: 8336–9341
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ . Protein measurement with the folic phenol reagent J Biol Chem 1951 193: 265–270
Nakai H, Iwaki Y, Kay MA, Couto LB . Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver J Virol 1999 73: 5438–5447
Acknowledgements
We wish to thank Dr Jude Samulski for pXX2 and pXX6 plasmids, Office of Technology Development, University of North Carolina at Chapel Hill; Dr Shie-Liang Hsieh for AAV type 2 plasmid; Dr Hsu Ma for help in the packaging of AAV, pXX2 and pXX6; Dr Szu-Hao Kung for help in the CsCl2 centrifugation and AAV separation; Dr Seiichi Tsujino for providing laboratory support in National Institute of Neuroscience, Japan. This work was partially supported by a grant from National Science Council, Taiwan (NSC89-2314-B075-014).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lin, CY., Ho, CH., Hsieh, YH. et al. Adeno-associated virus-mediated transfer of human acid maltase gene results in a transient reduction of glycogen accumulation in muscle of Japanese quail with acid maltase deficiency. Gene Ther 9, 554–563 (2002). https://doi.org/10.1038/sj.gt.3301672
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301672
Keywords
This article is cited by
-
Genetic analysis of an F2 intercross between two strains of Japanese quail provided evidence for quantitative trait loci affecting carcass composition and internal organs
Molecular Biology Reports (2014)
-
Potential of AAV vectors in the treatment of metabolic disease
Gene Therapy (2008)
-
Integrated maps in quail (Coturnix japonica) confirm the high degree of synteny conservation with chicken (Gallus gallus) despite 35 million years of divergence
BMC Genomics (2006)
-
Sustained correction of glycogen storage disease type II using adeno-associated virus serotype 1 vectors
Gene Therapy (2005)